The Lancet Gastroenterology & Hepatology in conversation with
En podkast av The Lancet Group
88 Episoder
-
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease
Publisert: 12.7.2023 -
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis
Publisert: 7.6.2023 -
Adelina Artenie on the incidence of HIV and HCV in people who inject drugs
Publisert: 10.5.2023 -
Johan Burisch on the costs of inflammatory bowel disease in high-income settings
Publisert: 12.4.2023 -
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease
Publisert: 8.2.2023 -
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer
Publisert: 23.1.2023 -
Dan Turner on vedolizumab in children with IBD
Publisert: 6.1.2023 -
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
Publisert: 9.11.2022 -
James Alexander on immune responses to COVID-19 vaccination in patients with IBD
Publisert: 5.10.2022 -
Filip Knop on liraglutide for bile acid diarrhoea
Publisert: 7.9.2022 -
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma
Publisert: 4.8.2022 -
Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer
Publisert: 6.7.2022 -
Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas
Publisert: 14.6.2022 -
Juan Pablo Arab on NAFLD public health policies in the Americas
Publisert: 9.5.2022 -
Sarah Blach on hepatitis C virus epidemiology
Publisert: 6.4.2022 -
Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection
Publisert: 23.3.2022 -
Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis
Publisert: 9.3.2022 -
Swati Patel on early-onset colorectal cancer
Publisert: 9.2.2022 -
Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands
Publisert: 10.12.2021 -
Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa
Publisert: 11.11.2021
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
